Table 4.
Comparison of attempt strategies by mortality difference (discounted life years) and incremental cost-effectiveness (dollars per discounted life year)
| Modeled Patient | Survival Difference (AVF − AVG) | ICER (AVF Versus AVG) | Survival Difference (AVF − Catheter) | ICER (AVF Versus Catheter) |
|---|---|---|---|---|
| 40-yr-old nondiabetic man | 2.59 | $34,464 | 3.49 | $45,603 |
| 40-yr-old nondiabetic woman | 1.67 | $14,410 | 2.98 | $43,338 |
| 40-yr-old diabetic man | 1.06 | $10,311 | 1.30 | $18,863 |
| 40-yr-old diabetic woman | 0.35 | Dominant | 1.00 | $10,284 |
| 60-yr-old nondiabetic man | 1.25 | $29,208 | 1.73 | $43,330 |
| 60-yr-old nondiabetic woman | 0.52 | Dominant | 1.39 | $40,547 |
| 60-yr-old diabetic man | 0.44 | $350 | 0.48 | $1496 |
| 60-yr-old diabetic woman | −0.001 | >$100,000 | 0.28 | Dominant |
| 80-yr-old nondiabetic man | 0.48 | $18,102 | 0.66 | $36,600 |
| 80-yr-old nondiabetic woman | 0.08 | Dominant | 0.49 | $34,563 |
| 80-yr-old diabetic man | 0.17 | $172 | 0.10 | Dominant |
| 80-yr-old diabetic woman | −0.03 | >$100,000 | 0.05 | Dominant |
Survival differences are reported in years. AVF, AV fistula; AVG, AV graft; ICER, incremental cost-effectiveness ratio; dominant, AVF has lower cost and superior survival.